Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S5.62
P/E—
Fwd P/E21.74
PEG1.20
52W— – —
RSI—
Target$174.95 (+19.0%)
Beta1.24
Div0.71%
Loading chart…
RSI ()
Loading patterns…
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 48
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
5Bullish
4Bearish
0Neutral
Key Signals 1
▲ Double Bottom
Major reversal
2026-07-23 · $138.36
Two lows ~$125.46 — bullish reversal confirmed
Learn more →
Momentum Signals 8
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ Bull Flag
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
88%
7/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$174.95
+19.0% upside
Low $155
—
High $190
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
53.65%Last 12 Months
Operating Margin
25.56%Last 12 Months
Return on Equity
20.97%Last 12 Months
Revenue Growth
8.10%Year over Year
Free Cash Flow
1.06BLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
56.34Most Recent Quarter
Current Ratio
2.05Most Recent Quarter
Cash
1.76BMost Recent Quarter
Total Debt
4.15BMost Recent Quarter
Net Debt
—Most Recent Quarter
How A Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 41.43B |
| Enterprise Value | 43.81B |
| Trailing P/E | 28.26 |
| Forward P/E | 21.74 |
| PEG Ratio (5yr) | 1.20 |
| Price/Sales (ttm) | 5.62 |
| Price/Book (mrq) | 5.63 |
| EV/Revenue | 5.94 |
| EV/EBITDA | 21.06 |
Share Statistics
| Avg Vol (3m) | 2.20M |
| Shares Outstanding | 281.97M |
| Float | 280.96M |
| % Held by Insiders | 0.19% |
| % Held by Institutions | 95.47% |
| Short Ratio | 2.76 |
| Short % of Float | 2.29% |
Profitability
| Gross Margin | 53.65% |
| Operating Margin (ttm) | 25.56% |
| Profit Margin | 19.53% |
| Return on Assets (ttm) | 8.63% |
| Return on Equity (ttm) | 20.97% |
Income Statement
| Revenue (ttm) | 7.37B |
| Revenue Growth (yoy) | 8.10% |
| Gross Profit (ttm) | 3.96B |
| EBITDA | 2.08B |
| Net Income (ttm) | 1.44B |
| Diluted EPS (ttm) | 5.20 |
| EPS Growth (yoy) | 8.50% |
Balance Sheet
| Total Cash (mrq) | 1.76B |
| Total Debt (mrq) | 4.15B |
| Debt / Equity (mrq) | 56.34 |
| Current Ratio (mrq) | 2.05 |
| Book Value / Share | 26.11 |
| Operating CF (ttm) | 1.61B |
| Free Cash Flow (ttm) | 1.06B |
Trading & Dividends
| Beta (5Y) | 1.24 |
| 50-Day MA | 142.99 |
| 200-Day MA | 131.60 |
| Fwd Dividend Yield | 0.71% |
| Payout Ratio | 19.98% |
Income
Dividend Yield
0.71%Last 12 Months
Annual Rate
1.02Forward
Payout Ratio
19.98%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 19.98%
Monthly Dividends
Ownership Breakdown
Institutional 95.47%
Insider 0.19%
Public 4.3%
Short Interest
2.29% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in A in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|